|
25 |
Further Guidance on the Involvement of the Private Sector and the Utilization of Off-site Facilities as Vaccination Sites |
April 05, 2021 |
|
26 |
Vaccination of Local Chief Executives in Critical and High Risk Areas |
April 05, 2021 |
|
27 |
Vaccination of Senior Citizens with CoronaVac (Sinovac) |
April 07, 2021 |
|
28 |
Temporary Suspension of AstraZeneca to Individuals Below 60 Years Old |
April 08, 2021 |
|
29 |
Vaccination of Clerks, Interns and Students Rotating in Hospitals |
April 12, 2021 |
|
30 |
Oversight and Reporting of the Implementation of Hospitals, Private Sector, Government Agencies, and NGOs |
April 13, 2021 |
|
31 |
Reminder on the Vaccination of Priority Group A4: Frontline Personnel in Essential Sectors |
April 20, 2021 |
|
32 |
Guidance on the Resumption Schedule of AstraZeneca Vaccination to Persons Below 60 Years Old |
April 25, 2021 |
|
34 |
Advisory on the Roll-out of the Support Supervision Activities to all Vaccination Sites |
April 29, 2021 |
|
35 |
Guidance on the Use of AstraZeneca Vaccines from the COVAX Facility and the Resumption of the Administration of AstraZeneca Vaccines to Individuals below 60 Years Old |
May 07, 2021 |
|
35-A |
Ensuring the Second Dose Administration of AstraZeneca Vaccines |
July 25, 2021 |
|
36 |
Additional Guidance on the Administration of AstraZeneca Vaccines from the COVAX Facility and Vaccination Roll-out |
May 09, 2021 |
